Current perspectives on drug treatment for preterm labour

Journal of Obstetrics and Gynaecology

Volumn 18, Issue 4, 1998, Pages 309-314

  Cole, Rebecca M ^a   Lamont, R F ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; ERGOTAMINE; GLYCERYL TRINITRATE; INDOMETACIN; MAGNESIUM SULFATE; NIFEDIPINE; NIMESULIDE; NITRIC OXIDE; OXYTOCIN; OXYTOCIN ANTAGONIST; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; SALBUTAMOL; SULINDAC; TERBUTALINE; UTERUS SPASMOLYTIC AGENT; VASOPRESSIN ANTAGONIST;

BONE DEFECT; BRAIN HEMORRHAGE; BRAIN INJURY; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; DRUG MECHANISM; DRUG SAFETY; DRUG SPECIFICITY; ENDOCRINE DISEASE; FEMALE; HEADACHE; HEART ARREST; HEART ARRHYTHMIA; HUMAN; HYPOGLYCEMIA; IMMUNOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; LUNG EDEMA; METABOLIC DISORDER; MYOMETRIUM; NEUROLOGIC DISEASE; PERINATAL MORTALITY; PREMATURE LABOR; PRIORITY JOURNAL; PROCTITIS; PULMONARY HYPERTENSION; REFLEX DISORDER; RESPIRATION DEPRESSION; REVIEW; SYSTOLIC HYPERTENSION; TACHYCARDIA; THYROID DISEASE; VISUAL IMPAIRMENT;

EID: 0031832439     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443619867001     Document Type: Review

References (35)

1. Bennett P. R. and Slater D. (1996) Cyclooxygenase 2 enzyme in labour. In: Improved Non-Steroidal Anti-Inflammatory Drugs: COX2 Enzyme Inhibitors, edited by Vare J., Bolting J. and Bolting R., p. 167. London, Kluwer Academic Publications.
2. Bennett P. R., Slater D., Sullivan M., Elder M. G. and Moore G. E. (1993) Changes in amniotic arachidonic acid metabolism associated with increased cyclooxygense gene expression. British Journal of Obstetrics and Gynaecology, 100, 1037-1042.
3. Besinger R. E. (1994) A systematic review of adverse events documented in the use of currently available treatment of pre-term labour. Research and Clinical Forums, 16, 89-122.
4. Besinger R. E. and Iannucci T. A. (1997) In: Preterm Labor, Tocolytic therapy. Edited by: Elder M. G., Romero R. and Lamont R. F., pp. 243-297. New York. Churchill Livingstone.
5. Bossmar T., Akerlund M., Fantoni G., Szamatowicz J., Melin P. and Maggi M. (1994) Receptors for an myometrial responses to oxytocin and vasopressin in preterm human pregnancy: effects of the oxytocin antagonist atosiban. American Journal of Obstetrics and Gynecology, 171, 1634-1642.
6. Canadian Preterm Labor Investigators Group (1992) Treatment of preterm labor with the beta-adrenergic agonist ritodrine. New England Journal of Medicine, 327, 308-312.
7. Carlan S. J., O'Brien W. F., O'Leary T. D. and Mastrogiannis D. (1992) Randomized comparative trial of indomethacin and sulindac for the treatment of refractile preterm labor. Obstetrics and Gynecology, 79, 223-228.
8. Carsten M. E. and Miller J. D. (1987) A new look at uterine muscle contraction. American Journal of Obstetrics and Gynecology, 157, 1303-1315.
9. Dennes W. J. B., Slater D. M. and Bennett P. R. (1997) Nitric oxide synthase mRNA expression in human fetal membranes: a possible role in partuition. Biochemical and Biophysical Research Communications, 233, 276-278.
10. Duggan D. E., Hare L. E., Ditzler C. A., Lei B. W. and Kwan K. C. (1977) The disposition of sulindac. Clinical Pharmacology and Therapeutics, 21, 326-335.
11. Goodwin T. M., Millar L., North L., Abram L. S., Weglein R. C. and Holland M. L. (1995) The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions. American Journal of Obstetrics and Gynecology, 173, 913-917.
12. Goodwin T. M., Paul R., Silver H., Spellacy W., Parsons M., Chez R., Hayashi R., Valenzuela G., Creasy G. W. and Merriman R. (1994) The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. American Journal of Obstetrics and Gynecology, 170, 474-847.
13. Goodwin T. M., Valenzuela G., Silver H., Hayashi R., Creasy G. W. and Lane R. (1996a) Treatment of preterm labor with the oxytocin antagonist atosiban. American Journal of Perinatology, 13, 143-146.
14. Goodwin T. M., Valenzuela G. J., Silver, H. and Creasy G. (1996b) Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban Study Group. Obstetrics and Gynecology, 88, 331-336.
15. Guiet-Bara A., Bara M. and Durlach J. (1985) Comparative study of the effect of two tocolytic agents (magnesium sulphate and alcohol) on the ionic transfer through the isolated human amnion. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 20, 297-304.
16. Hall M. H., Danielian P. and Lamont R. F. (1997) The importance of preterm birth. In: Preterm Labor, edited by Elder M. G., Lamont R. F. and Romero R., pp. 1-28. New York, Churchill Livingstone.
17. Keirse M. J. N. C. (1995) New perspectives for the effective treatment of preterm labor. American Journal of Obstetrics and Gynecology, 173, 618-628.
18. King J. F., Grant A., Keirse M. J. N. C. and Chalmers I. (1988) Beta-mimetics in preterm labour: an overview of randomised controlled trials. British Journal of Obstetrics and Gynaecology, 95, 211-222.
19. Kinsler V. A., Thornton S., Ashford M. L. J., Melin P. and Smith S. K. (1996) The effect of the oxytocin antagonists F314 and F792 on the in vitro contractility of human myometrium. British Journal of Obstetrics and Gynaecology, 103, 373-375.
20. Lamont R. F. (1993) The contemporary use of beta-agonists. British Journal of Obstetrics and Gynaecology, 100, 890-892.
21. Lamont R. F. and Elder M. G. (1996) The prevention of preterm birth. In: The Yearbook of the Royal College of Obstetricians and Gynaecologists, edited by Studd J., pp. 369-382. London, Parthenon Publishing.
22. Lees C., Campbell S., Jauniaux E., Brown R., Ramsey B., Gibb D., Moncada S. and Martin J. (1994) Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. The Lancet, 343, 1325-1326.
23. Leonardi M. R. and Hankins G. D. V. (1992) What's new in tocolytics. Prevention of Prematurity, 19, 367-384.
24. Lopez Bernal A., Phaneuf S., Asboth G. and TambyRaja R. L. (1997) The myometrium and its contractions. In: Preterm Labor, Edited by Elder M. G., Romero R. and Lamont R. F., pp. 369-400. New York, Churchill Livingstone.
25. Lundin S., Broeders A. and Melin P. (1993) Pharmacokinetic properties of the tocolytic agent [Mpa-1, D-Tyr(Et)-2, Thr-4, Orn-8]-oxytocin (antocin) in healthy volunteers. Clinical Endocrinology, 39, 369-374.
26. Manning M., Miteva K., Pancheva S., S toev S., Wo N. C. and Chan W. Y. (1995) Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparisons with Atosiban. American Journal of Peptide and Protein Research, 46, 244-252.
27. Melin P. (1994) Development of an oxytocin antagonist-Atosiban. Research and Clinical Forums, 16, 155-168.
28. Mercer B. M. and Lewis R. (1997) Antibiotic therapy for preterm labor and preterm premature rupture of the membranes. In: Preterm Labor, edited by Elder M. G., Lamont R. F. and Romero R., pp. 299-317. New York, Churchill Livingstone.
29. Phaneuf S., Asboth G., MacKenzie I. Z., Melin P. and Lopez-Bernal A. L. (1994) Effect of oxytocin antagonists on the activation of human myometrium in vitro: Atosiban prevents oxytocin-induced desensitization. American Journal of Obstetrics and Gynecology, 171, 1627-1633.
30. Ramsay B., De Beider A., Campbell S., Moncada S. and Martin J. F. (1994) A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of pre-eclampsia. European Journal of Clinical Investigation, 24, 76-78.
31. Saade G. R., Taskin O., Belfort M. A., Erturan B. and Moise K. J. (1994) In vitro comparison of four tocolytic agents, alone and in combination. Obstetrics and Gynecology, 84, 374-378.
32. Shubert P. J. (1995) Atosiban. Clinical Obstetrics and Gynecology, 38, 722-724.
33. Slater D. M., Berger L. C., Newton R., Moore G. E. and Bennett P. R. (1995) Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term. American Journal of Obstetrics and Gynecology, 172, 77-82.
34. Thomson A. J., Lunan C. B., Cameron A. D., Cameron I. T., Greer I. A. and Norman J. E. (1997) Nitric oxide donors induce ripening of the cervix: a randomised controlled trial. British Journal of Obstetrics and Gynaecology, 104, 1054-1057.
35. Zeeman G. G., Khan-Dawood F. S. and Dawood M. Y. (1997) Oxytocin and its receptor in pregnancy and partuition: current concepts and clinical implications. Obstetrics and Gynecology, 89, 873-883.